Zimmer Biomet Holdings, Inc. (ZBH)

Market Cap	21.81B
Revenue (ttm)	7.60B
Net Income (ttm)	1.08B
Shares Out	199.04M
EPS (ttm)	5.26
PE Ratio	20.84
Forward PE	13.00
Dividend	$0.96 (0.88%)
Ex-Dividend Date	Dec 30, 2024

Volume	869,263
Open	108.99
Previous Close	108.94
Day's Range	108.47 - 109.97
52-Week Range	100.67 - 133.90
Beta	1.02
Analysts	Hold
Price Target	123.68 (+12.89%)
Earnings Date	Feb 6, 2025

About ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 18,000
• Stock Exchange: NYSE
• Ticker Symbol: ZBH
• Website: https://www.zimmerbiomet.com

Financial Performance

In 2023, Zimmer Biomet Holdings's revenue was $7.39 billion, an increase of 6.55% compared to the previous year's $6.94 billion. Earnings were $1.02 billion, an increase of 342.52%.

Analyst Forecast

According to 21 analysts, the average rating for ZBH stock is "Hold." The 12-month stock price forecast is $123.68, which is an increase of 12.89% from the latest price.

Price Target

$123.68

(12.89% upside)

Analyst Consensus: Hold